8-K: Premier Inc. Reports Mixed Fiscal-Year 2025 Second-Quarter Results; Reaffirms Guidance Midpoints

Premier Inc. reports mixed Q2 fiscal year 2025 results with revenue decline but reaffirms guidance midpoints and increases adjusted EPS guidance.

Summary

• Premier Inc. reported a net revenue of $240.3 million for Q2 fiscal year 2025, a 14% decrease compared to the previous year.
• The company experienced a GAAP net loss from continuing operations of $45.8 million, or $(0.60) per fully diluted share, including a $126.8 million impairment charge related to its data and technology business.
• Adjusted earnings per share excluding Contigo Health were $0.27.
• Net cash provided by operating activities from continuing operations was $193.7 million, and free cash flow was $73.9 million for the first six months of fiscal 2025.
• Premier reaffirmed guidance midpoints for total net revenue excluding Contigo Health and adjusted EBITDA, while increasing the midpoint of adjusted earnings per share guidance by $0.08.
• The company completed the sale of the network assets of Contigo Health in January 2025 and is working to divest the remaining assets before the end of the fiscal year.
• Supply Chain Services segment net revenue decreased 11% to $148.7 million, while Performance Services segment net revenue decreased 19% to $91.5 million.
• The company repurchased over 29 million shares of Class A common stock for $600 million as of January 2025.
• A quarterly cash dividend of $0.21 per share was declared, payable on March 15, 2025.
• Fiscal 2025 guidance includes total net revenue excluding Contigo Health of $940 million to $1.01 billion, adjusted EBITDA of $237 million to $253 million, and adjusted EPS of $1.26 to $1.34.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue declined and there was a significant impairment charge, the company reaffirmed guidance midpoints and increased adjusted EPS guidance. Management expresses confidence in the long-term strategy and the actions being taken to address the challenges in the Performance Services segment.

Positives

• The company reaffirmed the midpoints of its consolidated fiscal 2025 revenue and adjusted EBITDA guidance.
• Adjusted earnings per share guidance was increased to reflect the favorable impact of the additional $200 million share repurchase.
• The company completed the sale of the network assets of Contigo Health in January 2025.
• Gross administrative fees grew close to 4% overall.
• The company is making progress in addressing members representing approximately 69% of the group of GPO members that were part of the August 2020 restructure.
• The company expects to address greater than 75% of this group's fees by the end of fiscal year 2025.
• The company is seeing good growth in some of the non-acute categories.
• The company is increasing the midpoint of its revenue guidance range for Supply Chain Services by $25 million to reflect higher net administrative fees resulting from a favorable blended fee share.
• The company has added new members, including Aspire Health Partners and a recent competitive GPO win.
• The company expects a payment in the fourth quarter from a member that entered into a joint venture with another health system, which will require a phased termination of their agreement through fiscal 2028.

Negatives

• GAAP net loss from continuing operations of $46 million was mainly due to an impairment charge to goodwill of $127 million related to the data and technology business in the Performance Services segment.
• Net revenue of $240 million for the quarter decreased from the prior year period, driven by a decline in net administrative fees revenue in Supply Chain Services.
• The company experienced lower revenue in consulting services and an unfavorable product mix in applied sciences within the Performance Services segment.
• Adjusted EBITDA was $50 million, translating to a margin of 20.8% and declined largely due to lower revenue.
• The company is lowering the midpoint of its revenue guidance range for Performance Services by $25 million, resulting from the previously discussed short-term headwinds that were experiencing.

Risks

• The company's forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from historical results or from any future results or projections.
• The company's ability to advance its business strategies and improve healthcare is subject to risks and uncertainties.
• The company's ability to find a partner for its Contigo Health business and the potential benefits thereof is subject to risks and uncertainties.
• The company's ability to fund and conduct share repurchases pursuant to the outstanding share repurchase authorization and the potential benefits thereof is subject to risks and uncertainties.
• The payment of dividends at current levels or at all is subject to risks and uncertainties.
• The company's guidance on expected future financial performance and assumptions underlying that guidance is subject to risks and uncertainties.
• The company's expected effective income tax rate is subject to risks and uncertainties.

Future Outlook

Premier is reaffirming the midpoints of its consolidated fiscal 2025 revenue and adjusted EBITDA guidance, while increasing the midpoint of its adjusted earnings per share guidance. The company expects Supply Chain Services to perform better than initially anticipated, while Performance Services is expected to face short-term headwinds.

Management Comments

• Our overall revenue and profitability for the first half of fiscal 2025 were in line with our expectations resulting from better than expected results in our Supply Chain Services segment, said Michael J. Alkire, Premiers President and CEO.
• Importantly, we are reaffirming the midpoints of our consolidated fiscal 2025 revenue and adjusted EBITDA guidance, despite challenges in our Performance Services segment.
• We are also increasing our adjusted earnings per share guidance to reflect the favorable impact of the additional $200 million share repurchase completed in early January, consistent with our commitment to returning capital to stockholders.
• We remain confident in our long-term strategy and under Daves leadership, we plan to reinvigorate this business by recruiting new talent with a strong track record of delivering broad-based performance improvement at large health systems, refocusing our solutions and go-to-market strategy around key areas of differentiation, leveraging our performance improvement collaboratives more broadly in the market and extending our unique AI capabilities to new use cases while continuing to further penetrate the market in the areas we already serve, said Glenn Coleman, Chief Administrative and Financial Officer.

Industry Context

Premier Inc.'s results reflect the ongoing trends in the healthcare industry, including the focus on supply chain efficiency, performance improvement, and technology enablement. The company's efforts to diversify its supply chain and leverage data analytics align with the broader industry goals of reducing costs and improving patient outcomes.

Comparison to Industry Standards

• Premier's adjusted EBITDA margin of 20.8% is comparable to other healthcare technology and services companies, such as Cerner (now Oracle Health) and McKesson, although specific comparisons would require a deeper dive into their respective business models and accounting practices.
• The company's focus on share repurchases and dividend payments is consistent with the capital allocation strategies of many mature companies in the healthcare sector, such as Cardinal Health and AmerisourceBergen, which prioritize returning value to shareholders.
• Premier's efforts to diversify its supply chain and mitigate the impact of potential tariffs are in line with the strategies of other large healthcare providers and GPOs, such as HCA Healthcare and Vizient, which are actively working to build more resilient and diversified supply chains.

Management Changes

Stakeholder Impact

• Shareholders: Positive impact from increased adjusted EPS guidance and continued return of capital through share repurchases and dividends.
• Employees: Potential impact from the restructuring and refocusing of the Performance Services segment.
• Customers (Healthcare Providers): Continued focus on supply chain efficiency and performance improvement to help reduce costs and improve patient outcomes.
• Suppliers: Opportunities to partner with Premier on digital supply chain initiatives and real-world evidence studies.
• Creditors: Stable financial position and cash flow provide confidence in the company's ability to meet its obligations.

Next Steps

• Continue to execute on the digital supply chain strategy and expand partnerships.
• Reinvigorate the Performance Services segment by recruiting new talent and refocusing the go-to-market strategy.
• Further penetrate the market in existing areas and extend AI capabilities to new use cases.
• Complete the divestiture of the remaining assets of Contigo Health.
• Monitor and mitigate the potential impact of tariffs on the supply chain.
• Continue to return capital to stockholders through share repurchases and dividends.

Key Dates

Keywords

Premier Inc, financial results, supply chain services, performance services, adjusted EBITDA, adjusted EPS, revenue, guidance, Contigo Health, share repurchase, healthcare